FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1879660031> ?p ?o ?g. }

• W1879660031 abstract "Polydipsia is the intake of more than three litres of fluids per day. Primary polydipsia occurs when excessive drinking cannot be explained by an identified medical condition, and is not secondary to polyuria. The prevalence of this problem in psychiatric inpatients has been estimated at between 6 and 17%. It can hinder standard care and be a highly disabling, even life-threatening condition.To review the effect of pharmacological interventions for the treatment of psychosis-related polydipsia.We searched the Cochrane Schizophrenia Group's Register (January 2002 and February 2005) which is compiled by up-to-date methodical searches of BIOSIS, The Cochrane Library, CINAHL, Dissertation abstracts, EMBASE, LILACS, MEDLINE, PSYNDEX, PsycINFO, RUSSMED and Sociofile and is supplemented with hand searching of relevant journals and numerous conference proceedings. References of all identified studies were also searched for further trials.We included all randomised controlled trials involving people with a psychotic illness and secondary polydipsia, which evaluated drug treatments, and measured clinically meaningful outcomes.Working independently, we inspected citations, ordered papers, and then re-inspected and quality assessed the studies and extracted data. For homogeneous dichotomous data, we calculated the relative risk (RR), 95% confidence interval (CI), and, where appropriate, the number needed to treat (NNT) and the number needed to harm (NNH), on an intention-to-treat basis. We assumed that people who left the study early or who were lost to follow-up had no improvement. We calculated weighted mean differences (WMD) for continuous data. We excluded data if loss to follow-up was greater than 50%.We identified two small trials (Alexander 1991 and Nishikawa 1996) which fulfilled the inclusion criteria, (total n=17, duration 3-6 weeks). Few data were reported and, because of inappropriate use of crossover methodology, we could not include all of the data in this review. For the few chronically ill people in these trials, neither the 'active' tetracycline bacteriostatic agent, oral demeclocycline, nor the opiate antagonist naloxone, nor placebo, gave any suggestion of serious adverse effects for a period of up to six weeks. The studies did not report any useful data on measures of polydipsia, physical symptoms secondary to increased fluid intake, mental state, general functioning or economic outcomes.The trials offer little useful data to the clinician hoping to treat psychosis-related polydipsia with drugs, except that further evaluative studies need to be conducted in this area. Treatment of any sort for psychosis related polydipsia might only be informative within a well designed, conducted and reported randomised study. The two pioneering studies suggest that larger trials, though difficult, would not be impossible with adequate support and co-ordination." @default.
• W1879660031 created "2016-06-24" @default.
• W1879660031 creator A5017251359 @default.
• W1879660031 creator A5041147307 @default.
• W1879660031 date "2006-10-18" @default.
• W1879660031 modified "2023-10-16" @default.
• W1879660031 title "Pharmacological treatments for psychosis-related polydipsia" @default.
• W1879660031 cites W1501619595 @default.
• W1879660031 cites W1591259115 @default.
• W1879660031 cites W1731310238 @default.
• W1879660031 cites W1964838514 @default.
• W1879660031 cites W1970159743 @default.
• W1879660031 cites W1977185679 @default.
• W1879660031 cites W1978040764 @default.
• W1879660031 cites W1986593606 @default.
• W1879660031 cites W1986853886 @default.
• W1879660031 cites W2009450158 @default.
• W1879660031 cites W2015029502 @default.
• W1879660031 cites W2023839473 @default.
• W1879660031 cites W2037240326 @default.
• W1879660031 cites W2051495185 @default.
• W1879660031 cites W2058874144 @default.
• W1879660031 cites W2061293296 @default.
• W1879660031 cites W2070493581 @default.
• W1879660031 cites W2088376406 @default.
• W1879660031 cites W2115419613 @default.
• W1879660031 cites W2115437456 @default.
• W1879660031 cites W2123258253 @default.
• W1879660031 cites W2135029321 @default.
• W1879660031 cites W2157823046 @default.
• W1879660031 cites W2169346408 @default.
• W1879660031 cites W4320288061 @default.
• W1879660031 doi "https://doi.org/10.1002/14651858.cd003544.pub2" @default.
• W1879660031 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6984657" @default.
• W1879660031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17054176" @default.
• W1879660031 hasPublicationYear "2006" @default.
• W1879660031 type Work @default.
• W1879660031 sameAs 1879660031 @default.
• W1879660031 citedByCount "13" @default.
• W1879660031 countsByYear W18796600312014 @default.
• W1879660031 countsByYear W18796600312016 @default.
• W1879660031 countsByYear W18796600312021 @default.
• W1879660031 countsByYear W18796600312022 @default.
• W1879660031 crossrefType "journal-article" @default.
• W1879660031 hasAuthorship W1879660031A5017251359 @default.
• W1879660031 hasAuthorship W1879660031A5041147307 @default.
• W1879660031 hasBestOaLocation W18796600312 @default.
• W1879660031 hasConcept C118552586 @default.
• W1879660031 hasConcept C126322002 @default.
• W1879660031 hasConcept C134018914 @default.
• W1879660031 hasConcept C17744445 @default.
• W1879660031 hasConcept C187212893 @default.
• W1879660031 hasConcept C199539241 @default.
• W1879660031 hasConcept C27415008 @default.
• W1879660031 hasConcept C2776478404 @default.
• W1879660031 hasConcept C2779473830 @default.
• W1879660031 hasConcept C2779549880 @default.
• W1879660031 hasConcept C2779624480 @default.
• W1879660031 hasConcept C2780180277 @default.
• W1879660031 hasConcept C2781145037 @default.
• W1879660031 hasConcept C44249647 @default.
• W1879660031 hasConcept C555293320 @default.
• W1879660031 hasConcept C67774102 @default.
• W1879660031 hasConcept C71924100 @default.
• W1879660031 hasConcept C82789193 @default.
• W1879660031 hasConcept C95190672 @default.
• W1879660031 hasConceptScore W1879660031C118552586 @default.
• W1879660031 hasConceptScore W1879660031C126322002 @default.
• W1879660031 hasConceptScore W1879660031C134018914 @default.
• W1879660031 hasConceptScore W1879660031C17744445 @default.
• W1879660031 hasConceptScore W1879660031C187212893 @default.
• W1879660031 hasConceptScore W1879660031C199539241 @default.
• W1879660031 hasConceptScore W1879660031C27415008 @default.
• W1879660031 hasConceptScore W1879660031C2776478404 @default.
• W1879660031 hasConceptScore W1879660031C2779473830 @default.
• W1879660031 hasConceptScore W1879660031C2779549880 @default.
• W1879660031 hasConceptScore W1879660031C2779624480 @default.
• W1879660031 hasConceptScore W1879660031C2780180277 @default.
• W1879660031 hasConceptScore W1879660031C2781145037 @default.
• W1879660031 hasConceptScore W1879660031C44249647 @default.
• W1879660031 hasConceptScore W1879660031C555293320 @default.
• W1879660031 hasConceptScore W1879660031C67774102 @default.
• W1879660031 hasConceptScore W1879660031C71924100 @default.
• W1879660031 hasConceptScore W1879660031C82789193 @default.
• W1879660031 hasConceptScore W1879660031C95190672 @default.
• W1879660031 hasLocation W18796600311 @default.
• W1879660031 hasLocation W18796600312 @default.
• W1879660031 hasLocation W18796600313 @default.
• W1879660031 hasLocation W18796600314 @default.
• W1879660031 hasOpenAccess W1879660031 @default.
• W1879660031 hasPrimaryLocation W18796600311 @default.
• W1879660031 hasRelatedWork W1532769656 @default.
• W1879660031 hasRelatedWork W2888618478 @default.
• W1879660031 hasRelatedWork W2957946008 @default.
• W1879660031 hasRelatedWork W2981900262 @default.
• W1879660031 hasRelatedWork W2984935528 @default.
• W1879660031 hasRelatedWork W4283011321 @default.
• W1879660031 hasRelatedWork W4294126851 @default.
• W1879660031 hasRelatedWork W4307384190 @default.
• W1879660031 hasRelatedWork W4361214646 @default.

• next